# Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

> **NCT00941577** · PHASE2 · COMPLETED · sponsor: **Altair Therapeutics, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AIR645
- **DRUG:** Physiologic saline solution

## Key facts

- **NCT ID:** NCT00941577
- **Lead sponsor:** Altair Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2010-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941577, "Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00941577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*